Delivery Order SPE2D018D0005-SPE2D325F7716

Award Date 3/6/25
Potential Completion Date 3/11/25
Potential Value $2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The $1,963.68 contract is for the supply of REAGENT ANTI-A B BIOCLONE 10ML BOTTLE OR, with a completion date of June 4, 2024. The contract does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. has provided a range of diagnostic solutions, medical...
This is a $1,767.32 fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov as a self-certified HUBZone joint venture. The contract is for the supply of anti-A,B bioclone laboratory reagents, with a period of performance through February 2025. Ortho-Clinical Diagnostics has demonstrated the capability to provide critical medical diagnostic...
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the delivery of 4567190755 ANTI-B BIOCLONE 15X10ML, a critical medical diagnostic product. It is a fixed price delivery order with economic price adjustment, with a completion date of February 12, 2025. No set-aside designation was used, indicating open competition....
This firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the provision of 150 milliliters of reagent anti-D bioclone. The contract has a potential value of $1,037.23 and a completion date of February 27, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that provides a range of diagnostic solutions, including analyzers, reagents, and...
The Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order contract to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, to provide 4563288114 - ANTI-A BIOCLONE 15X10ML. The contract, valued at $1,350.31, has a completion date of February 1, 2024. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and services to various federal agencies, including the...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for $1,037.23 to deliver 150ml vials of REAGENT ANTI-D BIOCLONE. The contract has a completion date of February 22, 2024. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to several federal agencies, including the...
This federal contract award, with a ceiling value of $1,037.23, was issued by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of November 25, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that has previously...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The contract is for the provision of 4567052599 - REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL, with a ceiling value of $1,037.23. The contract has a completion date of January 30, 2025 and was awarded on January 27, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified...
This federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturing company, was issued by the Defense Logistics Agency Troop Support Medical, part of the Department of Defense. The $2,748.81 firm fixed-price delivery order is for 4,564,275,330 units of an anti-A blood grouping reagent used in clinical laboratory applications. The award has no set-aside designation and an ultimate completion date of April 18, 2024. Ortho-Clinical Diagnostics has provided...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract, valued at $1,037.23, is for the provision of REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL, a medical supply item. The contract has a firm fixed price pricing type and a completion date of May 10, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and a self-certified HUBZone joint venture manufacturer of...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D325F7716
    Delivery Order

This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of reagent anti-A and anti-B bioclone bottles. The contract, valued at $1,963.68, is a delivery order placed by the Medical Supply Chain division of the Defense agency. The contract has a firm fixed-price pricing type and an ultimate completion date of March 11, 2025. The contract award does not indicate any set-aside designation, suggesting open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and has provided a variety of specialized medical diagnostic equipment and consumables to federal healthcare agencies through multiple indefinite delivery contracts (IDCs) and blanket purchase agreements (BPAs), demonstrating its capability to support critical medical testing infrastructure across the federal healthcare system.

Generated 6/5/25, 10:18 AM